New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
World's first living brain metastasis biobank paves way for personalized cancer treatment

World's first living brain metastasis biobank paves way for personalized cancer treatment

At 18 Spanish hospitals, when a patient with brain metastasis undergoes surgery, they can donate a tiny part of their brain to the first repository of brain metastasis living samples in the world, bas
World medicine November 07,2023
World's first living brain metastasis biobank paves way for personalized cancer treatment

World's first living brain metastasis biobank paves way for personalized cancer treatment

At 18 Spanish hospitals, when a patient with brain metastasis undergoes surgery, they can donate a tiny part of their brain to the first repository of brain metastasis living samples in the world, bas
World medicine November 07,2023
Pilot Awards for Global Brain Health Leaders awarded to encourage innovative dementia research

Pilot Awards for Global Brain Health Leaders awarded to encourage innovative dementia research

Today, the Alzheimer's Association, Global Brain Health Institute (GBHI), and the UK-based Alzheimer's Society announced the most recent awardees of the Pilot Awards for Global Brain Health Le
World medicine November 07,2023
Pilot Awards for Global Brain Health Leaders awarded to encourage innovative dementia research

Pilot Awards for Global Brain Health Leaders awarded to encourage innovative dementia research

Today, the Alzheimer's Association, Global Brain Health Institute (GBHI), and the UK-based Alzheimer's Society announced the most recent awardees of the Pilot Awards for Global Brain Health Le
World medicine November 07,2023
Pediatric mental health crisis skyrocketed and persisted during the pandemic

Pediatric mental health crisis skyrocketed and persisted during the pandemic

Mental health crises among children and adolescents requiring emergency department care skyrocketed during the pandemic and have stayed elevated despite a return to normalcy, according to a study by W
World medicine November 07,2023
Pediatric mental health crisis skyrocketed and persisted during the pandemic

Pediatric mental health crisis skyrocketed and persisted during the pandemic

Mental health crises among children and adolescents requiring emergency department care skyrocketed during the pandemic and have stayed elevated despite a return to normalcy, according to a study by W
World medicine November 07,2023
SAMETA Trial Evaluates Efficacy of Savolitinib Plus Durvalumab in MET-Driven Papillary RCC

SAMETA Trial Evaluates Efficacy of Savolitinib Plus Durvalumab in MET-Driven Papillary RCC

The safety and efficacy achieved with the combination of savolitinib and durvalumab (Imfinzi) vs standard-of-care sunitinib (Sutent) or durvalumab monotherapy will be evaluated in patients withM
World medicine November 07,2023
SAMETA Trial Evaluates Efficacy of Savolitinib Plus Durvalumab in MET-Driven Papillary RCC

SAMETA Trial Evaluates Efficacy of Savolitinib Plus Durvalumab in MET-Driven Papillary RCC

The safety and efficacy achieved with the combination of savolitinib and durvalumab (Imfinzi) vs standard-of-care sunitinib (Sutent) or durvalumab monotherapy will be evaluated in patients withM
World medicine November 07,2023
Healthy eating may be a key player in COPD risk reduction

Healthy eating may be a key player in COPD risk reduction

In a recent study published inBMC Public Health,researchers investigated the association between diet quality measured by the Healthy Eating Index-2010 (HEI-2010) score and the odds of Chr
World medicine November 07,2023
Healthy eating may be a key player in COPD risk reduction

Healthy eating may be a key player in COPD risk reduction

In a recent study published inBMC Public Health,researchers investigated the association between diet quality measured by the Healthy Eating Index-2010 (HEI-2010) score and the odds of Chr
World medicine November 07,2023
PROSPECT Trial Looks to Add Effective Option for Patients With R/R PCNSL

PROSPECT Trial Looks to Add Effective Option for Patients With R/R PCNSL

Efforts to develop the first FDA-approved agent specifically for patients with primary central nervous system lymphoma (PCNSL) have been initiated with the phase 2 PROSPECT trial (NCT04947319).1“PCNSL
World medicine November 07,2023
PROSPECT Trial Looks to Add Effective Option for Patients With R/R PCNSL

PROSPECT Trial Looks to Add Effective Option for Patients With R/R PCNSL

Efforts to develop the first FDA-approved agent specifically for patients with primary central nervous system lymphoma (PCNSL) have been initiated with the phase 2 PROSPECT trial (NCT04947319).1“PCNSL
World medicine November 07,2023
Influence of healthy lifestyle habits on chronic disorders

Influence of healthy lifestyle habits on chronic disorders

In a recent editorial published inNutrients, researchers described the health benefits of regular exercise, a healthy diet, and adequate sleep.Study:Effects of Healthy Lifestyles on Chroni
World medicine November 07,2023
Influence of healthy lifestyle habits on chronic disorders

Influence of healthy lifestyle habits on chronic disorders

In a recent editorial published inNutrients, researchers described the health benefits of regular exercise, a healthy diet, and adequate sleep.Study:Effects of Healthy Lifestyles on Chroni
World medicine November 07,2023
Is health a human right? The American College of Physicians answers with an emphatic YES!

Is health a human right? The American College of Physicians answers with an emphatic YES!

In a recent position paper published in theAnnuals of Internal Medicine, representatives of the American College of Physicians (ACP's) Ethics, Professionalism, and Human Rights Committee hig
World medicine November 07,2023
Is health a human right? The American College of Physicians answers with an emphatic YES!

Is health a human right? The American College of Physicians answers with an emphatic YES!

In a recent position paper published in theAnnuals of Internal Medicine, representatives of the American College of Physicians (ACP's) Ethics, Professionalism, and Human Rights Committee hig
World medicine November 07,2023
PD-1 Inhibitors Demonstrate Promise as Salvage Therapy in R/R Extranodal NK/T-cell Lymphoma

PD-1 Inhibitors Demonstrate Promise as Salvage Therapy in R/R Extranodal NK/T-cell Lymphoma

According to a comparative analysis conducted based on propensity score matching, anti–PD-1 therapy with either pembrolizumab (Keytruda) or nivolumab (Opdivo) significantly improved overall survival (
World medicine November 07,2023
PD-1 Inhibitors Demonstrate Promise as Salvage Therapy in R/R Extranodal NK/T-cell Lymphoma

PD-1 Inhibitors Demonstrate Promise as Salvage Therapy in R/R Extranodal NK/T-cell Lymphoma

According to a comparative analysis conducted based on propensity score matching, anti–PD-1 therapy with either pembrolizumab (Keytruda) or nivolumab (Opdivo) significantly improved overall survival (
World medicine November 07,2023
New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.The INTER
World medicine November 07,2023
New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.The INTER
World medicine November 07,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com